Browsing byAuthorKim, Hyo Jin

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 8 of 8

Issue DateTitleAuthor(s)Type
2022Executive summary of the Korean Society of Nephrology 2021 clinical practice guideline for optimal hemodialysis treatment강은정Article
2021Executive Summary of the Korean Society of Nephrology 2021 Clinical Practice Guideline for Optimal Hemodialysis Treatment강은정Article
2008Final Report of "Korean Multicenter AML-2000 Trial": Intention to Treat Analysis Based on Cytogenctics Risk문영철Meeting Abstract
2009Induction Therapy with "3+7" Chemotherapy Plus ATRA Followed by Consolidations with Three Courses of Idarubicin Alone and Maintenance Therapy with ATRA in Newly Diagnosed Acute Promyelocytic Leukemia (APL) Has An Excellent Leukemia-Free Survival but Minimal Toxicity in Low and Intermediate Risk Groups성주명; 문영철Meeting Abstract
2022Long-term follow-up results of cytarabine-containing chemotherapy for acute promyelocytic leukemia성주명; 문영철; 김대영; 박영훈Article
2021Metabolic Acidosis Is an Independent Risk Factor of Renal Progression in Korean Chronic Kidney Disease Patients: The KNOW-CKD Study Results강은정Article
2022Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease이용현Review
2016SUR Approach for IV Estimation of Canonical Contagion Models신동완Article

BROWSE